Why the study?
Does dexmedetomidine cause QT prolongation in pediatric critical care patients?
Does dexmedetomidine cause QT prolongation in pediatric critical care patients?
Dexmedetomidine may unmask or cause marked QT prolongation in pediatric critical care patients, warranting vigilance.
Answers are grounded in this paper and cite their sources.
May prompt QTc monitoring with dexmedetomidine in pediatric critical care; hypothesis-generating from a single case report.
Dexmedetomidine is a selective alpha-2 adrenergic agonist that is used frequently for short-term sedation in children. It has been noted to cause hypertension, hypotension, bradycardia, and sinus pauses; however, QTc prolongation has not been reported with dexmedetomidine administration. We describe a case of marked QT prolongation with use of dexmedetomidine in a pediatric critical care setting. Clinicians should be vigilant about potential QT prolongation in patients on dexmedetomidine, particularly in those receiving multiple other medications.
No takes yet. Share an insight, caveat, or question.
Burns et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: